Praxi Pro Vita IVF Center of Roma, Rome, Italy.
Fertil Steril. 2010 Nov;94(6):2467-9. doi: 10.1016/j.fertnstert.2010.04.035. Epub 2010 May 26.
To compare IVF outcome in ovarian stimulation protocols with recombinant FSH plus recombinant LH versus hMG, 122 patients were randomized into two study groups: group A, patients treated with urinary hMG, and group B, patients treated with rFSH plus rLH. The two groups proved to be comparable to the main IVF outcome (pregnancy rate, implantation rate, oocytes, and embryos quality), with an increasing risk of ovarian hyperstimulation in the Pergoveris group.
为了比较重组促卵泡激素（rFSH）加重组人黄体生成素（rLH）与尿促性素（hMG）在卵巢刺激方案中对体外受精（IVF）结局的影响，将 122 名患者随机分为两组：A 组，患者接受尿 hMG 治疗；B 组，患者接受 rFSH 加 rLH 治疗。两组在主要 IVF 结局（妊娠率、着床率、卵母细胞和胚胎质量）方面表现相当，但 Pergroveris 组发生卵巢过度刺激的风险增加。
Zotero 插件